RR

Ripal Rasiklal Khamar

Active Director Director DIN 09594788
DIN 09594788 First appointment May 2022 Primary industry Software
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2022
Shareholding value •••• Premium profile

About Ripal Rasiklal Khamar

Data last updated:

Ripal Rasiklal Khamar is a Director at Procyl Therapeutics Private Limited (since 2023) and Director at Provi Life Sciences Private Limited (since 2022). The companies operate in Software and Chemicals and Materials. The largest current company by reported revenue is Procyl Therapeutics Private Limited at ₹25,000 (FY 2025).

DIN 09594788
Primary Designation Director
Industry Software
First Appointment 04 May 2022
Oldest Company Age 4 yrs
Largest company Procyl Therapeutics Private Limited · ₹25,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Procyl Therapeutics Private Limited U72200GJ2023PTC139287
Director17 Mar 20232023₹25,000 (FY 2025)Active
Provi Life Sciences Private Limited U24290GJ2022PTC131656
Director04 May 20222022Active

Directorship timeline

Open interactive timeline →
Procyl Therapeutics Private Limited
Provi Life Sciences Private Limited
Premium access

Shareholding and investment profile for Ripal Rasiklal Khamar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ripal Rasiklal Khamar

Ripal Rasiklal Khamar currently holds 2 directorships: Procyl Therapeutics Private Limited (Director, since 17 Mar 2023, revenue ₹25,000 (FY 2025)); Provi Life Sciences Private Limited (Director, since 04 May 2022).

Ripal Rasiklal Khamar was first appointed on 04 May 2022 as Director at Provi Life Sciences Private Limited. The most recent appointment on record is 17 Mar 2023 at Procyl Therapeutics Private Limited.

The current boards of Ripal Rasiklal Khamar's companies include Dharmeshkumar Amratlal Patel (Procyl Therapeutics Private Limited), Sivapriya Kirubakaran (Procyl Therapeutics Private Limited), Vijay Thiruvenkatam (Procyl Therapeutics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available